• Norfolk and Norwich University Hospital NHS Foundation Trust.
• Oxford University Hospital, John Radcliffe Hospital.
• Cambridge University Hospital, Addenbrookes Hospital NHS Foundation Trust.
• Queen Elizabeth Hospital, Birmingham.

If you think you are eligible (suitable) and you want to take part but your hospital is not running the trial, it is still possible to take part.

Talk to your PSC doctor or contact the nearest study site to you. Some people switch hospitals temporarily for the duration of the clinical trial so that their PSC care and clinical trial study visits are at the same hospital; or they have a  'shared care' agreement whereby they still see their regular hospital doctor but also the PSC specialist who is running the clinical trial. Most PSC doctors will be supportive and coordinate this for you.

Please get in touch with Martine at hello@pscsupport.org.uk if you need help joining a clinical trial at a different hospital.

The SABR-PSC study is investigating a drug called Brodalumab.

There are 7 study visits in total - 6 face-to-face and 1 remote consultation at the end of the trial period.

Study visits will take approximately 1 hour to complete, with the penultimate (the visit before the final one) study visit lasting approximately 2 hours.

You will be shown how to inject the drug under your skin so that you can do it yourself at home.

Every clinical trial sets out strict rules defining who can and can't take part. Find out in the KEY INFORMATION if you are likely to be eligible.